Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 31, 2016
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
Hugo Geerts, Penny A Dacks, Viswanath Devanarayan, et al.
Therapie
|
June 23, 2005
[Pharmacology of Alzheimer's disease: where do we go from here?]
François Sellal, André Nieoullon, Géraldine Michel, et al.
Dementia and Geriatric Cognitive Disorders
|
March 16, 2005
Pharmacology of Alzheimer's disease: appraisal and prospects
François Sellal, André Nieoullon, Géraldine Michel, et al.
ALTEX
|
April 11, 2022
The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possible
Manuela Cassotta, Hugo Geerts, Lise Harbom, et al.
Proteomics
|
January 15, 2002
Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view
Kelly Tilleman, Ilse Stevens, Kurt Spittaels, et al.
Neurobiology of Disease
|
December 31, 2002
In vitro studies of Flemish, Dutch, and wild-type beta-amyloid provide evidence for two-staged neurotoxicity
Samir Kumar-Singh, Ann Julliams, Rony Nuydens, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease
Hugo Geerts, Mike Walker, Rachel Rose, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 2, 2019
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
Hugo Geerts, John Wikswo, Piet H van der Graaf, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2024
Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
Chanchala Kaddi, Mengdi Tao, Silke Bergeler, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Daniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 31, 2016
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
Hugo Geerts, Penny A Dacks, Viswanath Devanarayan, et al.
Therapie
|
June 23, 2005
[Pharmacology of Alzheimer's disease: where do we go from here?]
François Sellal, André Nieoullon, Géraldine Michel, et al.
Dementia and Geriatric Cognitive Disorders
|
March 16, 2005
Pharmacology of Alzheimer's disease: appraisal and prospects
François Sellal, André Nieoullon, Géraldine Michel, et al.
ALTEX
|
April 11, 2022
The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possible
Manuela Cassotta, Hugo Geerts, Lise Harbom, et al.
Proteomics
|
January 15, 2002
Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view
Kelly Tilleman, Ilse Stevens, Kurt Spittaels, et al.
Neurobiology of Disease
|
December 31, 2002
In vitro studies of Flemish, Dutch, and wild-type beta-amyloid provide evidence for two-staged neurotoxicity
Samir Kumar-Singh, Ann Julliams, Rony Nuydens, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease
Hugo Geerts, Mike Walker, Rachel Rose, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 2, 2019
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
Hugo Geerts, John Wikswo, Piet H van der Graaf, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2024
Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
Chanchala Kaddi, Mengdi Tao, Silke Bergeler, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Daniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Page
of 8